LWAM
GILD icon

Legacy Wealth Asset Management’s Gilead Sciences GILD Stock Holding History

Legacy Wealth Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$938K Sell
7,422
-23
-0.3% -$3.03K 0.21% 133
2026
Q1 		$1.04M Buy
7,445
+65
+0.9% +$9.1K 0.25% 116
2025
Q4 		$906K Sell
7,380
-65
-0.9% -$7.9K 0.22% 133
2025
Q3 		$826K Sell
7,445
-40
-0.5% -$4.55K 0.2% 141
2025
Q2 		$830K Sell
7,485
-76
-1% -$8.09K 0.21% 122
2025
Q1 		$847K Sell
7,561
-190
-2% -$19.6K 0.23% 110
2024
Q4 		$716K Sell
7,751
-81
-1% -$7.29K 0.19% 156
2024
Q3 		$657K Buy
7,832
+56
+0.7% +$4.27K 0.18% 188
2024
Q2 		$534K Buy
7,776
+202
+3% +$13.5K 0.15% 216
2024
Q1 		$555K Buy
7,574
+41
+0.5% +$3.15K 0.15% 212
2023
Q4 		$610K Buy
7,533
+14
+0.2% +$1.09K 0.2% 168
2023
Q3 		$563K Buy
7,519
+56
+0.8% +$4.31K 0.21% 165
2023
Q2 		$575K Sell
7,463
-4,545
-38% -$362K 0.2% 172
2023
Q1 		$996K Sell
12,008
-136
-1% -$11.3K 0.36% 79
2022
Q4 		$1.04M Sell
12,144
-230
-2% -$18.2K 0.4% 75
2022
Q3 		$763K Sell
12,374
-355
-3% -$22.4K 0.33% 97
2022
Q2 		$787K Sell
12,729
-54
-0.4% -$3.34K 0.32% 125
2022
Q1 		$760K Buy
12,783
+489
+4% +$31.3K 0.27% 145
2021
Q4 		$893K Buy
12,294
+1,620
+15% +$112K 0.3% 128
2021
Q3 		$746K Buy
10,674
+419
+4% +$29.4K 0.34% 120
2021
Q2 		$706K Buy
10,255
+396
+4% +$26.4K 0.31% 131
2021
Q1 		$637K Buy
9,859
+397
+4% +$25.6K 0.29% 142
2020
Q4 		$551K Buy
+9,462
New +$571K 0.28% 150

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legacy Wealth Asset Management's GILD Position: Q2 2026 in Review

Legacy Wealth Asset Management reduced its Gilead Sciences (GILD) stake by 0.31% in Q2 2026, selling an estimated $3.03K and leaving 7,422 shares worth $938K. The position accounts for 0.21% of the portfolio, ranked #133.

Legacy Wealth Asset Management first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.04M in Q4 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Legacy Wealth Asset Management held 7,422 shares of Gilead Sciences worth $938K as of Q2 2026.
  • Legacy Wealth Asset Management sold 23 Gilead Sciences shares in Q2 2026, an estimated $3.03K.
  • Gilead Sciences made up 0.21% of Legacy Wealth Asset Management's portfolio in Q2 2026, its #133 holding.
  • Legacy Wealth Asset Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Legacy Wealth Asset Management's Gilead Sciences position peaked at $1.04M in Q4 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Legacy Wealth Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.